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K e y  M e s s a g e s 
1. Standardised acupuncture has only a mild 
hypnotic effect for residual insomnia associated 
with major depressive disorder (MDD). Its 
efficacy does not differ to that of minimal 
acupuncture or placebo control.
2. The within-group effect size for the primary 
outcome measure—sleep-diary-derived sleep 
efficiency—was 0.4 at 1-week post-treatment, 
but there was almost no change in actigraphy-
derived objective sleep parameters. 
3. Standardised acupuncture and minimal 
acupuncture were well-tolerated, with rates of 
discontinuation (secondary to adverse events) of 
5.0% and 3.3%, respectively. 
4. Residual insomnia associated with MDD partially 
responds to non-specific factors of acupuncture, 
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Introduction
Major depressive disorder (MDD) is a common 
psychiatric condition. A sizable proportion of 
patients with MDD partially respond to mainstream 
treatment and are left with residual symptoms, of 
which insomnia is the most common.1 Although 
pharmacological and psychological treatments 
may help to alleviate residual insomnia, both 
have limitations. The use of complementary and 
alternative medicine therapies for insomnia has 
become more common. Acupuncture is one of the 
most popular procedures. In 2011, we published 
the first randomised trial of electroacupuncture 
for residual insomnia associated with MDD.2 
Electroacupuncture and minimal acupuncture 
were comparable and more efficacious than 
placebo control. In the present study, we aimed to 
enhance the efficacy of acupuncture for insomnia by 
augmenting essential acupoints. We hypothesised 
that electroacupuncture was significantly more 
efficacious than minimal acupuncture and placebo 
acupuncture for the treatment of residual insomnia 
in MDD.
Methods
The study was a placebo-controlled, subject- 
and assessor-blinded, randomised trial. The use 
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of placebo needles was to control for the non-
specific effects of acupuncture and the natural 
course of illness. Using superficial needling at 
non-therapeutic points could test the relevance of 
specific acupuncture points, deep needling, and de 
qi. Patients were assessed at baseline, 1-week and 
5-week post-treatment. The study was registered at 
clinicaltrials.gov (identifier: NCT01707706).
 Patients were recruited from May 2011 to 
August 2013 at four regional psychiatric outpatient 
clinics in Hong Kong. Inclusion criteria were: (1) 
age 18-70 years, (2) a diagnosis of MDD based on 
the DSM-IV criteria, (3) insomnia ≥3 nights per 
week for at least 3 months, (4) Insomnia Severity 
Index (ISI) score ≥15 at screening and baseline, and 
(5) taking the same antidepressants at a fixed dose 
for at least 12 weeks prior to baseline and during 
the study. Exclusion criteria were: (1) a 17-item 
Hamilton Rating Scale for Depression (HRSD-17) 
score >18 at screening and baseline, (2) an apnoea-
hypopnoea index ≥10 or a periodic limb movement 
disorder index ≥15 as assessed by in-laboratory 
overnight polysomnography, (3) significant suicidal 
risk according to the HRSD-17 item on suicide 
(score ≥3). Eligible subjects were randomly assigned 
to electroacupuncture, minimal acupuncture, or 
placebo acupuncture in a ratio of 2:2:1. 
 Intervention was three times per week for three 
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but it fails to attain full remission. Further studies 
exploring individualised acupuncture, a longer 
course of acupuncture and cognitive behavioural 
therapy for this persistent problem are needed.
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consecutive weeks. All acupuncture treatments were 
performed by the same registered Chinese medicine 
practitioner who had at least 3 years of clinical 
experience. 
  For electroacupuncture, subjects were 
needled at bilateral Ear Shenmen, Sishencong (EX-
HN1), Anmian (EX), Neiguan (PC6), Shenmen 
(HT7), Sanyinjiao (SP6), as well as unilateral Yintang 
(EX-HN3) and Baihui (GV20). De qi was achieved 
if possible. An electric-stimulator was connected to 
the needles and delivered a constant-current, 0.4-ms, 
square-wave, brief-pulse stimulus of 4-Hz frequency 
to the subjects. The needles were left for 30 minutes 
and then removed.
 For minimal acupuncture, subjects were 
needled superficially at non-acupoints on the head, 
ears, wrists, and legs that have no therapeutic effects 
according to the traditional Chinese medicine 
(TCM) theory. The points on the limbs included 
bilateral ‘forearm’, 1 inch lateral to the middle point 
between Shaohai (HE3) and Shenmen (HE7); ‘upper 
arm’, 1 inch lateral to Tianfu (LU 3); and ‘lower leg’, 
0.5 inch dorsal to Xuanzhong (GB39). For points 
on the head, they included bilateral ‘head’, the 
middle point between Shuaigu (GB8) and Touwei 
(ST8); ‘forehead’, the middle point between Touwei 
(ST8) and Yangbai (GB14); ‘neck’, the middle point 
between Tianyou (TB16) and Tianrong (SI17); 
and ‘ear’, a point on the helix, inferior to the apex. 
Other treatment conditions were the same as in the 
electroacupuncture group. 
 For placebo acupuncture, subjects were treated 
by placing placebo needles at sites 1 inch beside the 
acupoints used in the electroacupuncture group. The 
needles were connected to an electric-stimulator, 
but with zero frequency and amplitude. 
 The primary outcome measure was the sleep-
diary-derived sleep efficiency. Secondary outcome 
measures included other sleep parameters derived 
from the sleep diary, actigraphy measures, ISI, 
Pittsburgh Sleep Quality Index (PSQI), HRSD-17, 
Hamilton Anxiety Rating Scale (HARS), Hospital 
Anxiety and Depression Scale (HADS), Somatic 
Symptom Inventory (SSI), Sheehan Disability Scale 
(SDS), Multidimensional Fatigue Inventory (MFI), 
Epworth Sleepiness Scale (ESS), 36-item Short Form 
Health Survey (SF-36), and Credibility of Treatment 
Rating Scale (CTRS). Dichotomous outcomes were 
the proportion of subjects who obtained a sleep-
diary-derived sleep efficiency of at least 85% or a 
sleep-onset latency (SOL) or wake time after sleep 
onset (WASO) of ≤30 minutes. After the sixth 
treatment, the success of blinding was tested by 
asking the participants which kind of acupuncture 
treatment they thought they had received. Adverse 
events were assessed after the third, sixth, and ninth 
sessions, using a standardised adverse events form. 
 The effects of the intervention over time were 
assessed using the mixed-effects model of group-
by-time interaction. Standardised effect size was 
computed by dividing the difference in means by the 
pooled standard deviation. 
Results
A total of 150 subjects (mean age, 49.3 years) were 
randomised; 79.3% were female. They had been 
diagnosed with MDD for a mean of 8.4 years; 
84.0% were taking antidepressants (Table 1). The 
electroacupuncture, minimal acupuncture, and 
placebo acupuncture groups were comparable in 
terms of sociodemographics, clinical features, and 
pharmacotherapy. Sixteen (10.7%) subjects dropped 
out, and 18 (12.0%) withdrew 5 weeks post-treatment 
(Fig). The attrition rate among the groups was 
comparable at 1-week and 5-week post-treatment 
(χ2 test, P>0.05).
 In mixed-effects model analysis, the between-
group difference was not significant in sleep-diary-
derived sleep efficiency, SOL, WASO, or sleep 
quality at 1-week or 5-week post-treatment (Table 
2), nor in the ISI and PSQI scores. Nonetheless, a 
greater reduction in dosage of hypnotics was noted 
in the placebo acupuncture group compared with 
the electroacupuncture and minimal acupuncture 
groups at 5-week post-treatment (group-by-time 
interaction, P=0.02).
 There was no significant group-by-time 
interaction in actigraphy-derived measures, HRSD-
17, HARS, HADS anxiety and depression, SSI, SDS, 
MFI, or ESS scores. Nonetheless, mixed-effects 
model showed that electroacupunc¬ture and 
minimal acupuncture achieved greater improvement 
in SF-36 physical component summary score than 
placebo acupuncture at 1-week and 5-week post-
treatment (group-by-time interaction, P<0.05). 
 A higher proportion of subjects in the 
electroacupuncture group achieved a SOL ≤30 
minutes compared with those with minimal 
acupuncture at 1-week post-treatment (P=0.04), 
but not those with placebo acupuncture. At 5-week 
post-treatment, the between-group difference was 
not significant. There was no significant difference in 
the proportion of participants who attained a sleep 
efficiency ≥85% or WASO ≤30 minutes at 1-week 
and 5-week post-treatment (χ2 test, all P>0.05). 
 There was no significant between-group 
difference in the CTRS score and the proportion of 
participants who correctly guessed, made a wrong 
guess, or had no idea which acupuncture treatment 
they had received (P=0.11). 
 Electroacupuncture and minimal acupuncture 
were well-tolerated, with rates of discontinuation 
(secondary to adverse events) of 5.0% and 3.3%, 
respectively. No serious adverse events were 
reported.
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Discussion
There was no evidence to support better efficacy of 
traditional needle acupuncture as an intervention for 
residual insomnia associated with MDD. Although 
a within-group effect size of >1.0 was noted in the 
ISI score, the effect size in sleep-diary-derived sleep 
efficiency was quite small. Only a few participants 
could achieve sleep efficiency ≥85% on completion 
of the 3-week acupuncture treatment, and there 
was almost no change in actigraphy-derived sleep 
parameters. These suggest that the TCM-style 
standardised acupuncture attained a response 
mostly by its non-specific effects; the mean sleep-
diary-derived sleep efficiency post-treatment was 
71.4%, indicating that acupuncture is not likely to 
be an adequate monotherapy for residual insomnia 
associated with MDD. 
 Our previous studies showed that 
electroacupuncture had slightly better efficacy 
than placebo acupuncture.2,3 Despite an enhanced 
acupuncture regimen, the hypnotic efficacy of 
electroacupuncture did not improve much in the 
current study. In addition, there was a greater placebo 
response that narrowed down the group difference. 
Some factors may have reduced the effectiveness of 
the traditional acupuncture. 
TABLE 1.  Demographics and clinical characteristics of subjects
Variables Mean±SD or No (%) of subjects
Electro-acupuncture 
(n=60)
Minimal 
acupuncture (n=60)
Placebo 
acupuncture (n=30)
Total (n=150)
Age (years) 48.8±9.9 50.9±9.5 47.4±9.5 49.3±9.7
No. of males:females 14:46 14:46 3:27 31:119
Education attainment (years) 10.7±2.9 10.4±3.4 11.6±3.0 10.8±3.2
Marital status
Never married 7 (11.7) 10 (16.7) 7 (23.3) 24 (16.0)
Married/cohabiting 33 (55.0) 36 (60.0) 19 (63.3) 88 (58.7)
Divorced/widowed 20 (33.3) 14 (23.3) 4 (13.3) 38 (25.3)
Occupation 
Professional and associate professional 3 (5.0) 4 (6.7) 1 (3.3) 8 (5.3)
Skilled and semi-skilled worker 11 (18.3) 7 (11.7) 3 (10.0) 21 (14.0)
Unskilled worker 8 (13.3) 5 (8.3) 3 (10.0) 16 (10.7)
Retired 9 (15.0) 11 (18.3) 5 (16.7) 25 (16.7)
Unemployed/housework 29 (48.3) 33 (55.0) 18 (60.0) 80 (53.3)
Insomnia duration (years) 8.7±7.1 12.0±11.4 9.2±8.4 10.1±9.3
Chronic medical illnesses 16 (26.7) 13 (21.7) 8 (26.7) 37 (24.7)
Insomnia Severity Index 19.6±3.0 20.2±3.6 19.6±2.7 19.8±3.2
Pittsburgh Sleep Quality Index 14.1±3.0 14.7±2.5 15.0±3.5 14.5±2.9
Age of onset of depression (years) 39.9±10.0 40.9±10.5 38.6±9.2 40.0±10.0
Depression duration (years) 7.5±6.1 8.9±12.9 9.3±15.9 8.4±11.4
17-item Hamilton Rating Scale for Depression 10.4±4.2 9.9±4.1 11.5±4.0 10.4±4.2
Current antidepressant use 51 (85.0) 48 (80.0) 27 (90.0) 126 (84.0)
Selective serotonin reuptake inhibitors 27 (45.0) 16 (26.7) 14 (46.7) 57 (38.0)
Serotonin and noradrenalin reuptake inhibitors 8 (13.3) 5 (8.3) 1 (3.3) 14 (9.3)
Tricyclic antidepressants and others 6 (10.0) 15 (25.0) 5 (16.7) 26 (17.3)
Others 1 (1.7) 2 (3.3) 3 (10.0) 6 (4.0)
Combination 9 (15.0) 10 (16.7) 4 (13.3) 23 (15.3)
Current hypnotics use 27 (45.0) 26 (43.3) 16 (53.3) 69 (46.0)
Benzodiazepines 7 (11.7) 5 (8.3) 5 (16.7) 17 (11.3)
Non-benzodiazepine hypnotics 12 (20.0) 9 (15.0) 5 (16.7) 26 (17.3)
Combination of benzodiazepines and non-
benzodiazepine hypnotics
7 (11.7) 9 (15.0) 4 (13.3) 20 (13.3)
Antihistamine 1 (1.7) 3 (5.0) 2 (6.7) 6 (4.0)
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FIG.  Flowchart of the subjects
Assessed for eligibility (n=975)
Excluded (n=536)
- Refused to participate (n=100)
- No major depressive disorder history (n=98)
- Lost contact or incompatible working schedule (n=98)
- Other psychiatric disorders (n=66): schizophrenia (n=30), bipolar disorder (n=25), 
alcohol/drug dependence (n=10), post-traumatic stress disorder (n=1)   
- No insomnia complaint (n=42)
- Received acupuncture 12 months prior to study (n=42)
- Irregular dose of antidepressants and hypnotics (n=25)
- Unstable physical illness (n=21)
- Not outpatient department patient in recruitment sites (n=15)
- Specific sleep disorders (n=10): parasomnia (n=2), obstructive sleep apnoea (n=8)
- Inability to comprehend assessment tools due to illiteracy (n=9)
- Age <18 or >70 years (n=6), non-Chinese (n=2), shift worker (n=1)
- Clinician deemed unsuitable for study (n=1)
Excluded (n=289)
- Refused to give consent (n=93)
- Insomnia Severity Index <15 (n=52), not meeting insomnia diagnostic criteria (n=7)
- Lost contact (n=39)
- Specific sleep disorder detected by polysomnography or SLEEP-50 (n=34): parasomnia 
(n=2), PLMD (n=11), OSA (n=21)
- Inability to comprehend assessment tools (n=18)
- No major depressive disorder history (n=11)
- Irregular dose of antidepressants and hypnotics (n=8)
- Other psychiatric disorders (n=6): bipolar disorder (n=5), alcohol/drug dependence (n=1)
- Significant suicidal risk or 17-item Hamilton Rating Scale for Depression >18 (n=6)
- Received acupuncture 12 months prior to baseline (n=6)
- Unstable physical illness (n=3)
- Treatment and work schedule misfit (n=4), shift worker (n=1)
- Deceased (n=1)
Eligible for face-to-face interview and 
polysomnography screening (n=439)
Randomisation (n=150)
Electroacupuncture (n=60)
Analysed (n=60) Analysed (n=60) Analysed (n=30)
Completed treatment (n=52);
Withdrew due to adverse event (n=3); 
Schedule misfit (n=5) 
Completed 1-week post-intervention (n=51); 
Increased hypnotic dose (n=1)
Completed 5-week post-intervention (n=43); 
Lost contact (n=5); 
Refused follow-up (n=3)
Completed 5-week post-intervention (n=42); 
Lost contact (n=4); 
Refused follow-up (n=4)
Completed 5-week post-intervention (n=27); 
Sleep affected by jetlag (n=1);
Refused follow-up (n=1)
Completed 1-week post-intervention (n=50); 
Increased hypnotic dose (n=3)
Completed 1-week post-intervention (n=29)
Completed treatment (n=29); 
Schedule misfit (n=1)
Completed treatment (n=53);
Withdrew due to adverse event (n=2); 
Treatment schedule misfit (n=3); 
Mobility restricted by illness (n=1);  
Lost interest in treatment (n=1)
Minimal acupuncture (n=60) Placebo acupuncture (n=30)
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TABLE 2.  Sleep diary and actigraphy measures across study time points
* Only subjects taking hypnotics and completed the study were analysed: electroacupuncture (n=27), minimal acupuncture (n=23), and placebo 
acupuncture (n=14)
† Post hoc group-by-time interaction: electroacupuncture vs placebo acupuncture (P=0.01), minimal acupuncture vs placebo acupuncture (P=0.06), 
electroacupuncture vs minimal acupuncture (P=0.69)
‡ Post hoc group-by-time interaction: electroacupuncture vs placebo acupuncture (P=0.09), minimal acupuncture vs placebo acupuncture (P=0.76), 
electroacupuncture vs minimal acupuncture (P=0.02)
Outcome measure Electroacupuncture 
(n=60)
Minimal acupuncture 
(n=60)
Placebo acupuncture 
(n=30)
P value 
(group-
by-time 
interaction)Mean±SE Within-
group effect 
size
Mean±SE Within-
group effect 
size
Mean±SE Within-
group effect 
size
Sleep diary
Sleep onset latency (mins)
Baseline 58.9±5.5 69.0±5.6 69.0±7.8
1-week post-treatment 47.5±5.6 0.27 48.5±5.8 0.46 54.9±7.8 0.33 0.33
5-week post-treatment 46.4±6.1 0.28 44.9±6.3 0.52 50.4±8.2 0.42 0.52
Total sleep time (mins)
Baseline 318.7±10.3 314.6±10.4 338.6±14.5
1-week post-treatment 345.5±10.5 -0.33 364.1±10.8 -0.60 369.5±14.5 -0.39 0.24
5-week post-treatment 352.9±11.6 -0.40 367.8±12.0 -0.61 382.2±15.3 -0.53 0.47
Wake time after sleep onset (mins)
Baseline 62.8±6.7 62.2±6.8 48.7±9.5
1-week post-treatment 46.3±6.9 0.31 43.4±7.1 0.35 48.2±9.5 0.01 0.16
5-week post-treatment 48.5±7.5 0.26 46.1±7.7 0.29 41.6±10.0 0.13 0.41
Sleep efficiency (%)
Baseline 64.6±2.0 62.4±2.0 64.0±2.8
1-week post-treatment 71.4±2.0 0.44 72.8±2.1 0.65 68.3±2.8 0.20 0.13
5-week post-treatment 71.1±2.3 0.39 72.3±2.3 0.59 74.0±3.0 0.44 0.09
Equivalent dose of hypnotics in 
diazepam (mg/d)*
Baseline 9.9±1.7 8.3±1.8 5.4±2.4
1-week post-treatment 8.6±1.7 0.10 5.3±1.9 0.21 4.0±2.4 0.11 0.60
5-week post-treatment 9.5±1.7 0.03 7.9±1.9 0.03 2.6±2.4 0.21 0.02†
Actigraphy
Sleep onset latency (mins)
Baseline 31.2±4.1 30.1±4.0 29.2±5.7
1-week post-treatment 33.9±4.1 -0.08 29.8±4.1 0.01 35.1±5.8 -0.13 0.57
5-week post-treatment 33.4±4.5 -0.07 27.4±4.5 0.08 24.2±6.0 0.11 0.43
Total sleep time (mins)
Baseline 387.3±13.5 390.7±13.4 396.8±18.9
1-week post-treatment 395.1±13.8 -0.07 415.0±13.6 -0.23 391.2±19.4 0.05 0.47
5-week post-treatment 392.9±14.2 -0.05 389.1±14.3 0.01 398.1±19.4 -0.01 0.72
Wake time after sleep onset (mins)
Baseline 53.4±4.3 70.3±4.2 76.4±6.0
1-week post-treatment 60.6±4.3 -0.22 65.9±4.3 0.13 74.5±6.1 0.06 0.03‡
5-week post-treatment 55.3±4.6 -0.06 67.0±4.7 0.10 81.9±6.2 -0.16 0.05 
Sleep efficiency (%)
Baseline 78.8±1.4 76.0±1.3 76.9±1.9
1-week post-treatment 78.3±1.4 0.05 76.2±1.4 -0.02 76.5±1.9 0.04 0.88
5-week post-treatment 78.7±1.4 0.01 77.7±1.4 -0.16 77.3±1.9 -0.04 0.65
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 In terms of TCM theory, acupuncture should 
be customised according to TCM diagnoses and 
clinical response to acupuncture treatment. We 
are uncertain whether individualised acupuncture 
would achieve better efficacy. Another potential 
factor is the length of treatment. The 3-week 
treatment period may be too short, and a difference 
between ‘real’ and ‘placebo’ acupuncture might 
have emerged if the treatment had been longer. The 
other potential factor relates to the biophysiologic 
mechanism of acupuncture.4 Previous studies have 
shown that acupuncture can enhance a sympatho-
inhibitory effect, opioid-dependent analgesic effect, 
and nocturnal melatonin secretion. It is uncertain 
whether these acupuncture-induced biophysiologic 
effects failed to occur in most of our subjects who 
were using antidepressants, sedatives, or hypnotics. 
 Nonetheless, the current study included 
a well-documented screening process, proper 
randomisation, placebo acupuncture needles, 
validated subjective scales, objective measures, 
and comprehensive adverse event monitoring. In 
addition, the sample size is the largest to date among 
other published studies.5 Almost all subjects were 
unable to tell the kind of acupuncture they had 
received, so the blinding was successful. 
Conclusion
The effectiveness of acupuncture as an intervention 
for residual insomnia in MDD was mild at best, 
mainly owing to its non-specific effects. After 3 
weeks of thrice-weekly acupuncture treatment, a 
high proportion of patients remained significantly 
affected by insomnia. It is uncertain whether 
TCM pattern-based individualised acupuncture 
or acupuncture treatment of longer duration can 
improve its effectiveness for insomnia. Further 
studies are needed to explore treatments for this 
debilitating and persistent problem, which could 
affect the long-term outcome of MDD. Cognitive-
behavioural therapy is a promising treatment for 
insomnia and its applicability as an intervention 
for patients with residual insomnia associated with 
MDD should be explored.
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